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Table 1. AIDS cases and annual rates per 100,000 population, by state, reported July 1992










June 1994 Cumulative totals




< 13 years old Total 
 
Alabama 703 17.0 559 13.4 2,710 46 2,756
Alaska 31 5.3 74 12.4 222 3 225
Arizona 1,104 28.8 647 16.4 3,501 16 3,517
Arkansas 429 17.9 288 11.9 1,441 22 1,463
California 15,281 49.5 14,432 46.2 72,035 398 72,433
Colorado 1,087 31.4 881 24.7 4,205 22 4,227
Connecticut 1,457 44.4 1,306 39.8 5,272 127 5,399
Delaware 308 44.6 262 37.4 1,025 10 1,035
District of Columbia 1,078 184.2 1,580 273.1 6,414 90 6,504
Florida 9,113 67.6 7,742 56.6 37,979 876 38,855
Georgia 2,203 32.5 2,216 32.0 10,887 114 11,001
Hawaii 202 17.5 321 27.4 1,408 12 1,420
Idaho 66 6.2 57 5.2 248 2 250
Illinois 2,808 24.2 2,791 23.9 12,582 153 12,735
Indiana 758 13.4 729 12.8 3,023 25 3,048
Iowa 195 7.0 98 3.5 649 7 656
Kansas 304 12.1 271 10.7 1,231 8 1,239
Kentucky 297 7.9 298 7.9 1,359 13 1,372
Louisiana 1,205 28.2 1,225 28.5 5,903 83 5,986
Maine 78 6.3 137 11.1 507 4 511
Maryland 1,999 40.7 2,240 45.1 8,704 193 8,897
Massachusetts 1,909 31.9 2,040 33.9 8,527 145 8,672
Michigan 1,549 16.4 1,081 11.4 5,670 69 5,739
Minnesota 590 13.2 396 8.8 2,123 15 2,138
Mississippi 389 14.9 415 15.7 1,764 26 1,790
Missouri 1,636 31.5 823 15.7 5,257 37 5,294
Montana 27 3.3 30 3.6 152 2 154
Nebraska 153 9.6 106 6.6 530 6 536
Nevada 538 40.3 447 32.2 1,962 16 1,978
New Hampshire 93 8.3 90 8.0 446 6 452
New Jersey 3,393 43.4 5,285 67.1 21,974 522 22,496
New Mexico 279 17.6 163 10.1 948 3 951
New York 14,334 79.2 15,433 84.8 74,814 1,531 76,345
North Carolina 999 14.6 1,294 18.6 4,809 76 4,885
North Dakota 10 1.6 27 4.3 57 – 57
Ohio 1,192 10.8 1,330 12.0 5,835 73 5,908
Oklahoma 661 20.6 350 10.8 2,048 16 2,064
Oregon 661 22.2 579 19.1 2,651 11 2,662
Pennsylvania 2,149 17.9 2,823 23.4 11,224 151 11,375
Rhode Island 238 23.8 277 27.7 1,036 13 1,049
South Carolina 1,116 31.0 1,189 32.6 3,848 44 3,892
South Dakota 23 3.2 17 2.4 72 3 75
Tennessee 850 16.9 860 16.9 3,353 31 3,384
Texas 6,149 34.8 5,886 32.6 27,714 237 27,951
Utah 278 15.3 136 7.3 921 20 941
Vermont 28 4.9 81 14.1 212 3 215
Virginia 1,366 21.4 1,377 21.2 5,715 99 5,814
Washington 1,168 22.7 1,187 22.6 5,476 20 5,496
West Virginia 76 4.2 79 4.3 425 5 430
Wisconsin 627 12.6 400 7.9 1,959 22 1,981
Wyoming 37 8.0 21 4.5 112 – 112
 
Subtotal 83,224 32.6 82,376 31.9 382,939 5,426 388,365
 
Guam 2 1.5 1 0.7 14 – 14
Pacific Islands, U.S. – – – – 2 – 2
Puerto Rico 2,572 71.7 2,688 74.3 12,546 299 12,845










Totals include 345 persons whose state of residence is unknown.
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Table 2. AIDS cases and annual rates per 100,000 population, by metropolitan area with
500,000 or more population, reported July 1992 through June 1993, July 1993
through June 1994; and cumulative totals, by area and age group, through 





June 1994 Cumulative totals 




<13 years old Total 
 
Akron, Ohio 38 5.7 62 9.2 264 – 264
Albany-Schenectady, N.Y. 214 24.5 148 16.8 779 17 796
Albuquerque, N.Mex. 170 27.6 79 12.5 542 1 543
Allentown, Pa. 72 11.9 98 16.0 356 5 361
Ann Arbor, Mich. 48 9.5 39 7.6 211 4 215
Atlanta, Ga. 1,500 47.7 1,483 45.9 7,913 59 7,972
Austin, Tex. 497 55.2 530 57.1 2,107 16 2,123
Bakersfield, Calif. 130 22.1 130 21.5 440 3 443
Baltimore, Md. 1,388 57.0 1,481 60.5 5,553 142 5,695
Baton Rouge, La. 135 24.7 170 30.7 614 12 626
Bergen-Passaic, N.J. 398 30.8 798 61.4 2,886 57 2,943
Birmingham, Ala. 248 28.9 193 22.2 865 11 876
Boston, Mass. 1,693 29.9 1,765 31.0 7,599 129 7,728
Buffalo, N.Y. 197 16.5 104 8.7 746 10 756
Charleston, S.C. 239 45.2 188 35.0 761 8 769
Charlotte, N.C. 233 19.2 259 20.9 970 10 980
Chicago, Ill. 2,443 32.3 2,424 31.8 10,987 138 11,125
Cincinnati, Ohio 186 11.9 216 13.7 922 12 934
Cleveland, Ohio 368 16.6 338 15.2 1,624 29 1,653
Columbus, Ohio 243 17.4 355 25.1 1,308 6 1,314
Dallas, Tex. 1,655 59.2 1,187 41.6 6,735 27 6,762
Dayton, Ohio 123 12.8 96 9.9 553 8 561
Denver, Colo. 917 53.5 674 38.1 3,434 15 3,449
Detroit, Mich. 1,094 25.4 656 15.2 3,921 51 3,972
El Paso, Tex. 109 17.3 83 12.8 368 2 370
Fort Lauderdale, Fla. 1,068 82.1 1,136 86.3 5,929 120 6,049
Fort Worth, Tex. 375 26.4 318 22.0 1,548 15 1,563
Fresno, Calif. 150 18.6 158 19.2 614 7 621
Gary, Ind. 80 13.0 76 12.2 306 2 308
Grand Rapids, Mich. 112 11.6 85 8.7 393 3 396
Greensboro, N.C. 148 13.7 167 15.3 766 12 778
Greenville, S.C. 215 25.2 234 27.2 680 2 682
Harrisburg, Pa. 64 10.6 107 17.6 396 5 401
Hartford, Conn. 422 37.6 588 52.4 1,767 28 1,795
Honolulu, Hawaii 164 19.0 226 26.0 1,050 9 1,059
Houston, Tex. 2,144 60.7 2,075 57.1 10,584 91 10,675
Indianapolis, Ind. 344 24.2 415 28.7 1,506 10 1,516
Jacksonville, Fla. 793 83.2 348 35.9 2,273 52 2,325
Jersey City, N.J. 414 74.6 783 140.6 3,461 82 3,543
Kansas City, Mo. 728 45.0 361 22.1 2,477 11 2,488
Knoxville, Tenn. 59 9.7 108 17.3 319 2 321
Las Vegas, Nev. 424 43.7 344 33.7 1,517 15 1,532
Little Rock, Ark. 173 32.9 98 18.4 548 9 557
Los Angeles, Calif. 5,194 57.4 4,780 52.7 24,957 157 25,114
Louisville, Ky. 148 15.3 130 13.3 595 8 603
Memphis, Tenn. 330 31.9 311 29.7 1,190 11 1,201
Miami, Fla. 2,456 122.3 2,884 141.9 11,911 320 12,231
Middlesex, N.J. 325 31.0 364 34.3 1,789 47 1,836
Milwaukee, Wis. 322 22.2 219 15.0 1,053 14 1,067
Minneapolis-Saint Paul, Minn. 526 20.1 337 12.7 1,872 12 1,884
Mobile, Ala. 135 27.2 88 17.4 565 8 573
Monmouth-Ocean City, N.J. 335 33.4 332 32.7 1,521 42 1,563
Nashville, Tenn. 249 24.3 245 23.5 1,027 12 1,039
Nassau-Suffolk, N.Y. 946 35.8 580 21.8 3,579 71 3,650
New Haven, Conn. 905 55.5 609 37.4 3,058 94 3,152
New Orleans, La. 630 48.4 672 51.4 3,474 46 3,520
New York, N.Y. 11,769 137.6 13,705 160.0 64,459 1,380 65,839
Newark, N.J. 1,245 64.7 2,168 112.3 8,955 232 9,187
Norfolk, Va. 274 18.3 372 24.4 1,282 30 1,312
Oakland, Calif. 1,087 50.6 978 45.2 4,858 29 4,887
Oklahoma City, Okla. 286 29.1 140 14.1 954 2 956
Omaha, Nebr. 117 17.8 70 10.6 378 1 379
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Orange County, Calif. 589 23.7 568 22.7 3,234 22 3,256
Orlando, Fla. 859 65.8 431 32.2 2,584 49 2,633
Philadelphia, Pa. 1,733 35.1 2,272 45.8 8,743 118 8,861
Phoenix, Ariz. 780 33.5 431 18.0 2,520 10 2,530
Pittsburgh, Pa. 192 8.0 269 11.2 1,273 8 1,281
Portland, Oreg. 612 38.1 444 27.0 2,258 8 2,266
Providence, R.I. 221 24.2 261 28.6 972 12 984
Raleigh-Durham, N.C. 187 20.6 264 28.2 1,015 19 1,034
Richmond, Va. 359 40.1 260 28.6 1,209 15 1,224
Riverside-San Bernardino, Calif. 882 31.2 987 33.8 3,428 33 3,461
Rochester, N.Y. 227 21.0 194 17.8 909 8 917
Sacramento, Calif. 403 28.4 435 30.1 1,779 18 1,797
Saint Louis, Mo. 772 30.7 442 17.4 2,548 23 2,571
Salt Lake City, Utah 248 22.0 119 10.3 816 14 830
San Antonio, Tex. 329 23.9 642 45.7 2,063 19 2,082
San Diego, Calif. 1,395 53.6 1,224 46.5 5,800 35 5,835
San Francisco, Calif. 3,817 234.7 3,459 213.0 19,659 29 19,688
San Jose, Calif. 398 26.0 476 31.1 1,849 11 1,860
San Juan, P.R. 1,696 90.4 1,596 84.2 7,890 197 8,087
Sarasota, Fla. 131 26.3 183 36.6 708 15 723
Scranton, Pa. 53 8.3 35 5.5 220 3 223
Seattle, Wash. 897 42.2 772 35.7 4,019 12 4,031
Springfield, Mass. 178 29.7 270 44.9 791 15 806
Stockton, Calif. 80 15.9 136 26.6 400 12 412
Syracuse, N.Y. 170 22.6 98 12.9 588 6 594
Tacoma, Wash. 92 14.8 127 20.1 428 7 435
Tampa-Saint Petersburg, Fla. 1,311 62.2 782 37.0 4,303 64 4,367
Toledo, Ohio 83 13.5 51 8.3 305 6 311
Tucson, Ariz. 254 36.8 166 23.5 743 5 748
Tulsa, Okla. 217 29.7 119 16.0 629 5 634
Ventura, Calif. 122 17.8 77 11.2 432 2 434
Washington, D.C. 2,031 46.6 2,748 62.1 11,326 163 11,489
West Palm Beach, Fla. 831 92.3 591 64.7 3,380 118 3,498
Wichita, Kans. 86 17.2 72 14.2 330 2 332
Wilmington, Del. 235 44.3 219 40.9 787 9 796
Youngstown, Ohio 28 4.6 31 5.1 172 – 172
 
Metropolitan areas with
500,000 or more population 71,992 45.0 71,418 44.2 336,179 4,855 341,034
 
Central counties 70,638 48.2 70,097 47.4 330,397 4,761 335,158
Outlying counties 1,354 10.1 1,321 9.6 5,782 94 5,876
 
Metropolitan areas with 
50,000 to 500,000 population 8,882 19.1 8,456 18.0 37,597 545 38,142
 
Central counties 8,417 20.3 7,945 18.9 35,322 498 35,820
Outlying counties 465 9.2 511 9.9 2,275 47 2,322
 









Totals include 1,903 persons whose area of residence is unknown.
 
Table 2. AIDS cases and annual rates per 100,000 population, by metropolitan area with
500,000 or more population, reported July 1992 through June 1993, July 1993
through June 1994; and cumulative totals, by area and age group, through 





June 1994 Cumulative totals 




<13 years old Total 
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Table 3. AIDS cases by age group, exposure category, and sex, reported July 1992 through
 June 1993, July 1993 through June 1994; and cumulative totals, by age group and
























exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
 
Men who have sex with men 42,120 (58) 37,991 (54) – – 42,120 (49) 37,991 (45) 211,779 (53)
Injecting drug use 16,782 (23) 17,441 (25) 6,090 (49) 6,138 (43) 22,872 (27) 23,581 (28) 98,367 (25)
Men who have sex with men 
and inject drugs 5,413 ( 7) 4,165 ( 6) – – 5,413 ( 6) 4,165 ( 5) 25,447 ( 6)
Hemophilia/coagulation disorder 895 ( 1) 586 ( 1) 21 ( 0) 17 ( 0) 916 ( 1) 603 ( 1) 3,404 ( 1)
Heterosexual contact: 2,604 ( 4) 2,838 ( 4) 4,709 (38) 5,457 (38) 7,313 ( 9) 8,296 (10) 27,281 ( 7)
 
Sex with injecting drug user 1,075 959 2,381 2,197 3,456 3,156 14,239
Sex with bisexual male – – 393 414 393 414 1,601
Sex with person with hemophilia 8 4 54 56 62 60 235
Sex with transfusion recipient 
with HIV infection 54 60 100 81 154 141 574
Sex with HIV-infected person, 
risk not specified 1,467 1,815 1,781 2,709 3,248 4,525 10,632
 
Receipt of blood transfusion, 










4,142 ( 6) 6,436 ( 9) 1,288 (10) 2,322 (16) 5,430 ( 6) 8,759 (10) 23,189 ( 6)
Adult/adolescent subtotal 72,567 (100) 69,955 (100) 12,555 (100) 14,309 (100) 85,122 (100) 84,268 (100) 396,015 (100)
 
Pediatric (<13 years old) 
exposure category 
 
Hemophilia/coagulation disorder 18 ( 4) 14 ( 3) – 1 ( 0) 18 ( 2) 15 ( 2) 214 ( 4)
Mother with/at risk for HIV infection: 383 (91) 438 (90) 391 (97) 470 (93) 774 (94) 908 (92) 5,095 (89)
 
Injecting drug use 136 134 134 150 270 284 2,192
Sex with an injecting drug user 62 75 58 62 120 137 969
Sex with a bisexual male 5 5 3 6 8 11 97
Sex with person with hemophilia 1 1 4 1 5 2 23
Sex with transfusion recipient 
with HIV infection 1 3 1 1 2 4 24
Sex with HIV-infected person, 
risk not specified 44 60 58 71 102 131 462
Receipt of blood transfusion, 
blood components, or tissue 17 12 10 8 27 20 123
Has HIV infection, risk not 
specified 117 148 123 171 240 319 1,205
 
Receipt of blood transfusion, 
blood components, or tissue 16 ( 4) 14 ( 3) 7 ( 2) 15 ( 3) 23 ( 3) 29 ( 3) 348 ( 6)
Risk not reported or identified 3 ( 1) 21 ( 4) 4 ( 1) 19 ( 4) 7 ( 1) 40 ( 4) 77 ( 1)
Pediatric subtotal 420 (100) 487 (100) 402 (100) 505 (100) 822 (100) 992 (100) 5,734 (100)
 
















Twenty-seven adults/adolescents and 2 children developed AIDS after receiving blood screened negative for HIV antibody. Eight additional adults
developed AIDS after receiving tissue or organs from HIV-infected donors. Three of the 8 received tissue or organs from a donor who was negative
for HIV antibody at the time of donation. See 
 






"Other" refers to 15 health-care workers who developed AIDS after occupational exposure to HIV-infected blood, as documented by evidence of sero-
conversion; to 4 patients who developed AIDS after exposure to HIV within the health-care setting; to 7 persons who acquired HIV infection perina-
tally and were diagnosed with AIDS after age 13; and to 1 person with intentional self-inoculation of blood from an HIV-infected person. "Risk not
reported or identified" refers to persons under investigation; persons who died, were lost to follow-up, or who declined interview; and persons who do
not report one of the exposures listed above after interview. See Figure 6.
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Table 4. Male adult/adolescent AIDS cases by exposure category and race/ethnicity, reported
July 1993 through June 1994, and cumulative totals, through June 1994, 
United States
 













Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
 
Men who have sex with men 23,829 (73) 142,906 (77) 8,330 (35) 40,500 (41) 5,232 (41) 25,645 (45)
Injecting drug use 3,536 (11) 15,104 ( 8) 8,931 (38) 36,426 (37) 4,900 (38) 21,854 (38)
Men who have sex with men 
and inject drugs 2,169 ( 7) 13,995 ( 8) 1,292 ( 5) 7,434 ( 7) 649 ( 5) 3,787 ( 7)
Hemophilia/coagulation disorder 439 ( 1) 2,677 ( 1) 77 ( 0) 310 ( 0) 55 ( 0) 267 ( 0)
Heterosexual contact: 602 ( 2) 2,080 ( 1) 1,537 ( 7) 4,963 ( 5) 675 ( 5) 1,958 ( 3)
 
Sex with an injecting drug user 215 977 562 2,519 178 747
Sex with person with hemophilia 1 14 – 3 3 6
Sex with transfusion recipient
with HIV infection 17 82 16 72 25 52
Sex with HIV-infected person, 
risk not specified 369 1,007 959 2,369 469 1,153
 
Receipt of blood tranfusion, 
blood components, or tissue 265 ( 1) 2,623 ( 1) 151 ( 1) 732 ( 1) 65 ( 1) 420 ( 1)




1,968 ( 6) 5,111 ( 3) 3,206 (14) 9,137 ( 9) 1,161 ( 9) 3,057 ( 5)
 
Total 32,808 (100) 184,496 (100) 23,524 (100) 99,502 (100) 12,737 (100) 56,988 (100)
















Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
 
Men who have sex with men 436 (76) 1,898 (79) 113 (57) 493 (62) 37,991 (54) 211,779 (61)
Injecting drug use 27 ( 5) 103 ( 4) 26 (13) 90 (11) 17,441 (25) 73,705 (21)
Men who have sex with men and
 inject drugs 20 ( 3) 74 ( 3) 28 (14) 133 (17) 4,165 ( 6) 25,447 ( 7)
Hemophilia/coagulation disorder 6 ( 1) 38 ( 2) 8 ( 4) 22 ( 3) 586 ( 1) 3,321 ( 1)
Heterosexual contact: 16 ( 3) 40 ( 2) 5 ( 3) 14 ( 2) 2,838 ( 4) 9,063 ( 3)
 
Sex with an injecting drug user 3 14 – 5 959 4,263
Sex with person with hemophilia – – – – 4 23
Sex with transfusion recipient 
with HIV infection 1 3 1 1 60 211
Sex with HIV-infected person, 
risk not specified 12 23 4 8 1,815 4,566
 
Receipt of blood tranfusion, 
blood components, or tissue 12 ( 2) 79 ( 3) 1 ( 1) 7 ( 1) 498 ( 1) 3,872 ( 1)
Risk not reported or identified 58 (10) 179 ( 7) 16 ( 8) 30 ( 4) 6,436 ( 9) 17,589 ( 5)
 








Includes 590 men whose race/ethnicity is unknown.
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Table 5. Female adult/adolescent AIDS cases by exposure category and race/ethnicity, 
reported July 1993 through June 1994, and cumulative totals, through June 1994,
United States
 













Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
 
Injecting drug use 1,326 (42) 5,426 (43) 3,510 (44) 14,160 (51) 1,273 (42) 4,923 (47)
Hemophilia/coagulation disorder 11 ( 0) 56 ( 0) 5 ( 0) 20 ( 0) 1 ( 0) 6 ( 0)
Heterosexual contact: 1,238 (39) 4,536 (36) 2,801 (35) 9,014 (33) 1,361 (45) 4,479 (43)
 
Sex with injecting drug user 516 2,131 1,075 4,968 583 2,798
Sex with bisexual male 159 766 174 576 73 220
Sex with person with hemophilia 41 168 8 26 6 14
Sex with transfusion recipient 
with HIV infection 30 203 26 79 23 67
Sex with HIV-infected person, 
risk not specified 492 1,268 1,518 3,365 676 1,380
 
Receipt of blood transfusion, 
blood components, or tissue 151 ( 5) 1,489 (12) 155 ( 2) 725 ( 3) 61 ( 2) 389 ( 4)




461 (14) 1,047 ( 8) 1,520 (19) 3,762 (14) 316 (10) 722 ( 7)
 
Total 3,187 (100) 12,554 (100) 7,991 (100) 27,681 (100) 3,012 (100) 10,519 (100)
















Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
 
Injecting drug use 8 (13) 43 (16) 15 (34) 65 (47) 6,138 (43) 24,660 (48)
Hemophilia/coagulation disorder – – 1 ( 0) – – – – 17 ( 0) 83 ( 0)
Heterosexual contact: 32 (52) 118 (45) 20 (45) 46 (33) 5,457 (38) 18,217 (36)
 
Sex with injecting drug user 11 35 12 30 2,197 9,976
Sex with bisexual male 8 34 – 3 414 1,601
Sex with person with hemophilia – 2 1 2 56 212
Sex with transfusion recipient 
with HIV infection 1 12 – – 81 363
Sex with HIV-infected person, 
risk not specified 12 35 7 11 2,709 6,065
 
Receipt of blood transfusion, 
blood components, or tissue
7 (11) 62 (23) 1 ( 2) 10 ( 7) 375 ( 3) 2,676 ( 5)
Risk not reported or identified 14 (23) 41 (15) 8 (18) 17 (12) 2,322 (16) 5,599 (11)
 








Includes 78 women whose race/ethnicity is unknown. 
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Table 6. Pediatric AIDS cases by exposure category and race/ethnicity, reported July 1993
through June 1994, and cumulative totals, through June 1994, United States
 













Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Hemophilia/coagulation disorder 8 ( 6) 144 (13) 5 ( 1) 31 ( 1) 2 ( 1) 35 ( 3)
Mother with/at risk for HIV infection: 118 (85) 751 (70) 552 (93) 3,038 (95) 227 (92) 1,261 (90)
 
Injecting drug use 42 329 161 1,296 78 550
Sex with injecting drug user 17 145 75 460 45 358
Sex with bisexual male 1 38 4 33 5 24
Sex with person with hemophilia 1 14 1 6 – 3
Sex with transfusion recipient 
with HIV infection 2 8 1 8 1 8
Sex with HIV-infected person, 
risk not specified 19 61 76 286 33 106
Receipt of blood transfusion, 
blood components, or tissue 6 35 11 62 3 26
Has HIV infection, risk not specified 30 121 223 887 62 186
 
Receipt of blood transfusion, blood 
components, or tissue 8 ( 6) 173 (16) 7 ( 1) 80 ( 3) 12 ( 5) 85 ( 6)




5 ( 4) 12 ( 1) 29 ( 5) 50 ( 2) 6 ( 2) 15 ( 1)
 
Total 139 (100) 1,080 (100) 593 (100) 3,199 (100) 247 (100) 1,396 (100)
















Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Hemophilia/coagulation disorder – – 3 (10) – – 1 ( 6) 15 ( 2) 214 ( 4)
Mother with/at risk for HIV infection: 8 (80) 18 (60) 1 (100) 16 (94) 908 (92) 5,095 (89)
 
Injecting drug use 1 4 1 8 284 2,192
Sex with injecting drug user – 2 – 2 137 969
Sex with bisexual male 1 2 – – 11 97
Sex with person with hemophilia – – – – 2 23
Sex with transfusion recipient 
with HIV infection – – – – 4 24
Sex with HIV-infected person, 
risk not specified 2 4 – 2 131 462
Receipt of blood transfusion, 
blood components, or tissue – – – – 20 123
Has HIV infection, risk not specified 4 6 – 4 319 1,205
 
Receipt of blood transfusion, blood
components, or tissue 2 (20) 9 (30) – – – – 29 ( 3) 348 ( 6)
Risk not reported or identified – – – – – – – – 40 ( 4) 77 ( 1)
 








Includes 12 children whose race/ethnicity is unknown.
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Table 7. AIDS cases in adolescents and adults under age 25, by sex and exposure category,
reported July 1993 through June 1994, and cumulative totals through June 1994, 
United States
 













Male exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
 
Men who have sex with men
 




14 ( 5) 18 ( 7) 79 ( 7) 257 (12) 266 (13) 1,505 (13)
 
Men who have sex with men 
and inject drugs
 








11 ( 4) 9 ( 3) 27 ( 2) 94 ( 4) 96 ( 5) 349 ( 3)
 
Sex with injecting drug user
 
6 3 13 40 27 160
 
Sex with person with hemophilia
 
– 1 1 – – 1
 
Sex with transfusion recipient 
with HIV infection
 
– – – 2 2 9
 
Sex with HIV-infected person, 
risk not specified
 
5 5 13 52 67 179
 
Receipt of blood transfusion,
blood components, or tissue
 
6 ( 2) 15 ( 6) 51 ( 4) 10 ( 0) 18 ( 1) 89 ( 1)
 








296 (100) 267 (100) 1,203 (100) 2,203 (100) 2,060 (100) 11,879 (100)
 












99 (70) 80 (47) 292 (52) 447 (54) 429 (51) 1,641 (49)
 
Sex with injecting drug user
 
43 31 155 224 183 921
 
Sex with bisexual male
 
6 5 16 30 27 138
 
Sex with person with hemophilia
 
1 1 7 6 13 35
 
Sex with transfusion recipient 
with HIV infection
 
– – 1 1 2 67
 
Sex with HIV-infected person, 
risk not specified
 
49 43 113 186 204 540
 
Receipt of blood transfusion, 
blood components, or tissue
 
10 ( 7) 8 ( 5) 46 ( 8) 15 ( 2) 13 ( 2) 89 ( 3)
 
Risk not reported or identified
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Table 8. AIDS cases by sex, age at diagnosis and race/ethnicity, reported through 














Age at diagnosis (years) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
 
Under 5 363 ( 0) 1,378 ( 1) 565 ( 1) 11 ( 0) 9 ( 1) 2,328 ( 1)
5-12 256 ( 0) 229 ( 0) 169 ( 0) 7 ( 0) 1 ( 0) 663 ( 0)
13-19 570 ( 0) 368 ( 0) 239 ( 0) 14 ( 1) 12 ( 2) 1,203 ( 0)
20-24 5,462 ( 3) 3,937 ( 4) 2,339 ( 4) 88 ( 4) 36 ( 5) 11,879 ( 03)
25-29 26,676 (14) 14,287 (14) 9,292 (16) 318 (13) 164 (21) 50,819 (15)
30-34 43,248 (23) 22,703 (22) 14,076 (24) 521 (21) 217 (27) 80,890 (23)
35-39 41,089 (22) 23,403 (23) 12,783 (22) 525 (22) 153 (19) 78,102 (22)
40-44 29,597 (16) 16,460 (16) 8,532 (15) 430 (18) 110 (14) 55,228 (16)
45-49 17,456 ( 9) 8,600 ( 9) 4,617 ( 8) 240 (10) 46 ( 6) 31,009 ( 9)
50-54 9,355 ( 5) 4,657 ( 5) 2,414 ( 4) 126 ( 5) 24 ( 3) 16,601 ( 5)
55-59 5,344 ( 3) 2,611 ( 3) 1,410 ( 2) 74 ( 3) 12 ( 2) 9,479 ( 3)
60-64 3,109 ( 2) 1,392 ( 1) 738 ( 1) 31 ( 1) 10 ( 1) 5,287 ( 2)
65 or older 2,590 ( 1) 1,084 ( 1) 547 ( 1) 44 ( 2) 5 ( 1) 4,278 ( 1)
Male subtotal 185,115 (100) 101,109 (100) 57,722 (100) 2,429 (100) 799 (100) 347,767 (100)
 
Female
Age at diagnosis (years)
 
Under 5 360 ( 3) 1,362 ( 5) 535 ( 5) 6 ( 2) 7 ( 5) 2,277 ( 4)
5-12 101 ( 1) 230 ( 1) 127 ( 1) 6 ( 2) – – 466 ( 1)
13-19 113 ( 1) 358 ( 1) 91 ( 1) 1 ( 0) 1 ( 1) 565 ( 1)
20-24 802 ( 6) 1,737 ( 6) 751 ( 7) 15 ( 5) 16 (11) 3,325 ( 6)
25-29 2,316 (18) 4,786 (16) 2,053 (18) 27 (10) 29 (20) 9,222 (17)
30-34 2,970 (23) 6,975 (24) 2,746 (25) 56 (20) 38 (26) 12,806 (24)
35-39 2,381 (18) 6,377 (22) 2,150 (19) 45 (16) 21 (14) 10,995 (20)
40-44 1,403 (11) 3,804 (13) 1,289 (12) 42 (15) 14 (10) 6,561 (12)
45-49 765 ( 6) 1,614 ( 6) 627 ( 6) 25 ( 9) 8 ( 6) 3,044 ( 6)
50-54 444 ( 3) 878 ( 3) 362 ( 3) 15 ( 5) 3 ( 2) 1,705 ( 3)
55-59 380 ( 3) 504 ( 2) 219 ( 2) 10 ( 4) 4 ( 3) 1,119 ( 2)
60-64 295 ( 2) 320 ( 1) 112 ( 1) 13 ( 5) 3 ( 2) 743 ( 1)
65 or older 685 ( 5) 328 ( 1) 118 ( 1) 16 ( 6) 1 ( 1) 1,149 ( 2)
















Includes 1 male and 1 female whose age at diagnosis is unknown, and 4 persons whose sex is unknown.
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 and deaths, by half-year and age group, through
June 1994, United States
 















Before 1981 88 87.5 30 8 75.0 1
1981 Jan.–June 102 89.2 37 10 80.0 2
July–Dec. 199 92.0 83 5 100.0 6
1982 Jan.–June 417 93.5 151 13 84.6 9
July–Dec. 717 91.4 295 16 87.5 4
1983 Jan.–June 1,329 93.4 525 32 100.0 14
July–Dec. 1,689 93.8 945 43 90.7 16
1984 Jan.–June 2,644 93.2 1,419 51 86.3 26
July–Dec. 3,465 93.6 2,009 62 85.5 24
1985 Jan.–June 5,056 92.6 2,862 109 78.9 47
July–Dec. 6,499 92.4 3,954 135 83.0 70
1986 Jan.–June 8,591 91.7 5,178 139 84.9 67
July–Dec. 10,176 91.8 6,689 193 73.6 96
1987 Jan.–June 13,391 90.3 7,783 226 76.1 121
July–Dec. 14,806 88.1 8,215 265 71.3 171
1988 Jan.–June 17,183  86.0 9,639 263 65.8 136
July–Dec. 17,661 85.7 11,013 343 63.6 179
1989 Jan.–June 20,524 81.9 12,643 367 61.9 172
July–Dec. 20,886 79.9 14,519 342 63.7 193
1990 Jan.–June 23,369 76.2 14,889 376 57.2 192
July–Dec. 22,976 72.6 15,832 392 48.5 197
1991 Jan.–June 26,978 66.9 16,715 377 48.0 169
July–Dec. 28,933 59.7 18,593 365 43.3 213
1992 Jan.–June 34,269 48.3 18,548 445 37.1 185
July–Dec. 36,969 37.9 19,386 378 35.4 214
1993 Jan.–June 36,726 23.4 19,764 356 28.7 230
July–Dec. 27,169 14.9 19,527 311 23.2 228
1994 Jan.–June 13,203 7.0 8,773 112 14.3 114
 
Total2 396,015 60.7 240,323 5,734 54.1 3,100
1Case-fatality rates are calculated for each half-year by date of diagnosis. Each 6-month case-fatality rate is the number of deaths ever reported
among cases diagnosed in that period (regardless of the year of death), divided by the number of total cases diagnosed in that period, multiplied by
100. For example, during the interval January through June 1982, AIDS was diagnosed in 417 adults/adolescents. Through June 1994, 390 of these
417 were reported as dead. Therefore, the case fatality rate is 93.5 (390 divided by 417, multiplied by 100). The case-fatality rates shown here may
be underestimates because of incomplete reporting of deaths. Reported deaths are not necessarly caused by HIV-related disease.
2Death totals include 307 adults/adolescents and 4 children known to have died, but whose dates of death are unknown.
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Table 10. AIDS cases by year of diagnosis and definition category, diagnosed through 














Definition category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Pre-1987 definition 130,826 (76) 30,464 (60) 32,364 (51) 26,383 (35) 11,031 (27) 231,068 (58)
1987 definition 36,714 (21) 15,349 (30) 18,164 (28) 16,331 (22) 7,171 (18) 93,729 (23)
1993 definition1 4,086 ( 2) 4,881 (10) 13,438 (21) 31,803 (43) 22,744 (56) 76,952 (19)
Pulmonary tuberculosis 756 710 1,289 1,966 876 5,597
Recurrent pneumonia 178 121 296 833 555 1,983
Invasive cervical cancer 34 23 43 82 52 234
Severe HIV-related 
immunosuppression2 3,132 4,035 11,830 28,953 21,278 69,228
Total 171,626 (100) 50,694 (100) 63,966 (100) 74,517 (100) 40,946 (100) 401,749 (100)
1Persons who meet only the 1993 AIDS surveillance case definition and whose date of diagnosis is before January 1993 were diagnosed retro-
spectively. The sum of diagnoses listed for the four conditions under the 1993 definition do not equal the 1993 definition total because some persons
have more than one diagnosis from the added conditions of pulmonary tuberculosis, recurrent pneumonia, and invasive cervical cancer.
2Defined as CD4+ T-lymphocyte count of less than 200 cells/µL or a CD4+ percentage less than 14  in persons with laboratory confirmation of HIV
infection.
Table 11. Health-care workers with documented and possible occupationally acquired 






Dental worker, including dentist – 7
Embalmer/morgue technician – 3
Emergency medical technician/paramedic – 9
Health aide/attendant 1 9
Housekeeper/maintenance worker 1 6
Laboratory technician, clinical 15 14
Laboratory technician, nonclinical 2 1
Nurse 13 19
Physician, nonsurgical 6 9
Physician, surgical – 1
Respiratory therapist 1 2
Technician, dialysis 1 1
Technician, surgical 2 1
Technician/therapist, other than those listed above – 4
Other health-care occupations – 2
Total 42 88
1Health-care workers are defined as those persons, including students and trainees, who have worked in a health-care, clinical, or HIV laboratory set-
ting at any time since 1978. See MMWR 1992;41:823-5.
2Health-care workers who had documented HIV seroconversion after occupational exposure or had other laboratory evidence of occupational infec-
tion: 36 had percutaneous exposure, 4 had mucocutaneous exposure, 1 had both percutaneous and mucocutaneous exposures, and 1 had an
unknown route of exposure. Thirty-eight  exposures were to blood from an HIV-infected person, 1 to visibly bloody fluid, 1 to an unspecified fluid, and
2 to concentrated virus in a laboratory. Fifteen of these health-care workers developed AIDS.
3These health-care workers have been investigated and are without identifiable behavioral or transfusion risks; each reported percutaneous or
mucocutaneous occupational exposures to blood or body fluids, or laboratory solutions containing HIV, but HIV seroconversion specifically resulting
from an occupational exposure was not documented.
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Table 12. Adult/adolescent AIDS cases by single and multiple exposure categories, reported
through June 1994, United States
AIDS cases
Exposure category No. (%)
Single mode of exposure
Men who have sex with men 204,140 (52)
Injecting drug use 82,127 (21)
Hemophilia/coagulation disorder 2,584 ( 1)
Heterosexual contact 26,408 ( 7)
Receipt of transfusion1 6,540 ( 2)
Receipt of transplant of tissues/organs or artificial insemination2 8 ( 0)
Other3 27 ( 0)
Single mode of exposure subtotal 321,807 (81)
Multiple modes of exposure
Men who have sex with men; injecting drug use 22,501 ( 6)
Men who have sex with men; hemophilia/coagulation disorder 103 ( 0)
Men who have sex with men; heterosexual contact 4,478 ( 1)
Men who have sex with men; receipt of transfusion/transplant 2,830 ( 1)
Injecting drug use; hemophilia/coagulation disorder 127 ( 0)
Injecting drug use; heterosexual contact 14,280 ( 4)
Injecting drug use; receipt of transfusion/transplant 1,244 ( 0)
Hemophilia/coagulation disorder; heterosexual contact 45 ( 0)
Hemophilia/coagulation disorder; receipt of transfusion/transplant 749 ( 0)
Heterosexual contact; receipt of transfusion/transplant 873 ( 0)
Men who have sex with men; injecting drug use; hemophilia/coagulation disorder 28 ( 0)
Men who have sex with men; injecting drug use; heterosexual contact 2,364 ( 1)
Men who have sex with men; injecting drug use; receipt of transfusion/transplant 445 ( 0)
Men who have sex with men; hemophilia/coagulation disorder; heterosexual contact 8 ( 0)
Men who have sex with men; hemophilia/coagulation disorder; receipt of transfusion/transplant 28 ( 0)
Men who have sex with men; heterosexual contact; receipt of transfusion/transplant 188 ( 0)
Injecting drug use; hemophilia/coagulation disorder; heterosexual contact 28 ( 0)
Injecting drug use; hemophilia/coagulation disorder; receipt of transfusion/transplant 28 ( 0)
Injecting drug use; heterosexual contact; receipt of transfusion/transplant 521 ( 0)
Hemophilia/coagulation disorder; heterosexual contact; receipt of transfusion/transplant 26 ( 0)
Men who have sex with men; injecting drug use; hemophilia/coagulation disorder; heterosexual contact; 6 ( 0)
Men who have sex with men; injecting drug use; hemophilia/coagulation disorder; receipt of transfusion/transplant 14 ( 0)
Men who have sex with men; injecting drug use; heterosexual contact; receipt of transfusion/transplant 87 ( 0)
Men who have sex with men; hemophilia/coagulation disorder; heterosexual contact; receipt of transfusion/transplant 4 ( 0)
Injecting drug use; hemophilia/coagulation disorder; heterosexual contact; receipt of transfusion/transplant 12 ( 0)
Men who have sex with men; injecting drug use; hemophilia/coagulation disorder; heterosexual contact; 
receipt of transfusion/transplant 2 ( 0)
Multiple modes of exposure subtotal 51,019 (13)
Risk not reported or identified4 23,162 ( 6)
Total 396,015 (100)
1Includes 27 adult/adolescents who developed AIDS after receiving blood screened negative for HIV antibody.
2Eight adults developed AIDS after receiving tissue, organs, or artificial insemination from HIV-infected donors. Three of the 8 received tissue or
organs from a donor who was negative for HIV antibody at the time of donation. See N Engl J Med 1992;326:726-32.
3"Other" refers to 15 health-care workers who developed AIDS after occupational exposure to HIV-infected blood, as documented by evidence of sero-
conversion; to 4 patients who developed AIDS after exposure to HIV within the health-care setting, as documented by laboratory studies; to 7 persons
who acquired HIV infection perinatally and were diagnosed with AIDS after age 13; and to 1 person with intentional self-inoculation of blood from an
HIV-infected person.
4See Figure 6.
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Figure 1. Male adult/adolescent AIDS annual rates per 100,000 population, for cases reported
July 1993 through June 1994, United States
Figure 2. Female adult/adolescent AIDS annual rates per 100,000 population, for cases 
reported July 1993 through June 1994, United States
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Figure 3. Male/adult adolescent AIDS cases reported July 1993 through June 1994, 
United States
Figure 4. Female adult/adolescent AIDS cases reported July 1993 through June 1994,
United States
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Figure 5. Pediatric AIDS cases reported July 1993 through June 1994, United States
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Figure 6. Results of investigations of adult/adolescent AIDS cases ever classified as risk not
 reported or identified, through June 1994, United States1
 
1Excludes 77 children under 13 years of age whose risk is not identified. An additional 269 children who were initially reported without risk informa-
tion have been reclassified after investigation.
2Cases associated with persons born in Pattern-II conuntries are no longer classified as heterosexual transmission. See Technical Notes.
3Investigations of these persons included patient interviews. Based on available information, these persons could not be reclassified into an exposure
category. This group includes persons possibly infected through heterosexual contact with a partner who is not known to be HIV infected or at high
risk for HIV infection; persons who may choose not to disclose high-risk information; and persons with possible occupational exposure. These 741
persons report heterosexual contact, sexually transmitted disease infections, non-injecting drug use, hepatitis infections, and occupational exposures
to blood or body fluids.
4Fifteen are health-care workers who developed AIDS after occupational exposure to HIV-infected blood, as documented by evidence of seroconver-
sion; 4 are patients who developed AIDS after exposure to HIV within the health-care setting, as documented by laboratory studies; 7 are persons
who acquired HIV infection perinatally and were diagnosed with AIDS after age 13; and 1 is a person with intentional self-inoculation of blood from an
HIV-infected person.
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Table 13. HIV infection cases (not AIDS) by state, reported July 1993 through June 1994, and
cumulative totals by state and age group, through June 1994, from states with 
confidential HIV infection reporting
July 1993–
June 1994 Cumulative totals
State of residence 




 <13 years old Total
Alabama (Jan. 1988) 564 3,434 27 3,461
Arizona (Jan. 1987) 395 2,921 24 2,945
Arkansas (July 1989) 266 1,115 12 1,127
Colorado (Nov. 1985) 529 5,050 27 5,077
Connecticut (July 1992)1 50 – 74 74
Idaho (June 1986) 53 311 2 313
Indiana (July 1988) 609 2,390 16 2,406
Louisiana (Feb. 1993) 1,468 2,744 12 2,756
Michigan (April 1992) 727 1,510 67 1,577
Minnesota (Oct. 1985) 291 1,992 21 2,013
Mississippi (Aug. 1988) 503 2,536 31 2,567
Missouri (Oct. 1987) 635 2,974 29 3,003
Nevada (Feb. 1992) 376 1,697 21 1,718
New Jersey (Jan. 1992) 3,287 7,222 271 7,493
North Carolina (Feb. 1990) 1,031 4,437 45 4,482
North Dakota (Jan. 1988) 29 56 – 56
Ohio (June 1990) 681 2,728 25 2,753
Oklahoma (June 1988) 211 1,460 7 1,467
South Carolina (May 1985) 907 5,238 65 5,303
South Dakota (Jan. 1988) 16 136 5 141
Tennessee (Jan. 1992) 799 2,130 25 2,155
Texas (Feb. 1994)1 54 – 54 54
Utah (April 1989) 121 775 5 780
Virginia (July 1989) 1,369 5,055 50 5,105
West Virginia (Jan. 1989) 98 290 2 292
Wisconsin (Nov. 1985) 288 1,807 19 1,826
Wyoming (June 1989) 12 67 – 67
Subtotal 15,369 60,075 936 61,011
Persons reported from states with  confidential HIV
reporting who were residents of  other states2 504 1,420 12 1,432
Total 15,873 61,495 948 62,443
1Connecticut and Texas have confidential HIV infection reporting for pediatric cases only.
2Includes 244 persons reported from states with confidential HIV infection reporting, but whose state of residence is unknown. See Technical Notes.
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Table 14. Male adult/adolescent HIV infection cases (not AIDS) by exposure category and
race/ethnicity, reported July 1993 through June 1994, and cumulative totals
through June 1994, from states with confidential HIV infection reporting1













Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
Men who have sex with men 2,839 (58) 13,594 (60) 1,572 (29) 6,549 (31) 211 (29) 944 (37)
Injecting drug use 506 (10) 1,948 ( 9) 1,304 (24) 4,584 (22) 269 (37) 759 (30)
Men who have sex with men and 
inject drugs 348 ( 7) 1,888 ( 8) 254 ( 5) 1,078 ( 5) 32 ( 4) 179 ( 7)
Hemophilia/coagulation disorder 79 ( 2) 290 ( 1) 19 ( 0) 59 ( 0) 1 ( 0) 8 ( 0)
Heterosexual contact: 134 ( 3) 534 ( 2) 432 ( 8) 1,743 ( 8) 50 ( 7) 133 ( 5)
Sex with an injecting drug user 46 157 126 465 17 52
Sex with person with hemophilia – 5 2 2 – 1
Sex with transfusion recipient 
with HIV infection 4 18 6 25 2 2
 Sex with HIV-infected person, 
risk not specified 84 354 298 1,251 31 78
Receipt of blood tranfusion, 
blood components, or tissue 30 ( 1) 174 ( 1) 30 ( 1) 117 ( 1) 5 ( 1) 17 ( 1)
Risk not reported or identified2 983 (20) 4,311 (19) 1,890 (34) 7,016 (33) 150 (21) 525 (20)
Total 4,919 (100) 22,739 (100) 5,501 (100) 21,146 (100) 718 (100) 2,565 (100)













Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
Men who have sex with men 13 (39) 59 (50) 26 (48) 142 (50) 4,723 (41) 21,522 (45)
Injecting drug use 4 (12) 11 ( 9) 11 (20) 40 (14) 2,111 (18) 7,423 (15)
Men who have sex with men and 
inject drugs – – 2 ( 2) 8 (15) 44 (16) 648 ( 6) 3,222 ( 7)
Hemophilia/coagulation disorder 3 ( 9) 3 ( 3) 1 ( 2) 5 ( 2) 103 ( 1) 370 ( 1)
Heterosexual contact: 3 ( 9) 5 ( 4) 3 ( 6) 10 ( 4) 638 ( 6) 2,461 ( 5)
Sex with an injecting drug user 2 2 – 2 198 689
Sex with person with hemophilia – – – – 2 8
Sex with transfusion recipient 
with HIV infection – – – – 12 45
Sex with HIV-infected person, 
risk not specified 1  3 3 8 426 1,719
Receipt of blood tranfusion, 
blood components, or tissue – – 2 ( 2) – – 3 ( 1) 66 ( 1) 322 ( 1)
Risk not reported or identified 10 (30) 35 (30) 5 ( 9) 39 (14) 3,257 (28) 13,004 (27)
Total 33 (100) 117 (100) 54 (100) 283 (100) 11,546 (100) 48,324 (100)
1See Table 13 for states with confidential HIV infection reporting.
2For HIV infection cases (not AIDS), "Risk not reported or identified" refers primarily to persons whose mode of exposure was not reported and who
have not been followed up to determine their mode of exposure, and to a smaller number of persons who are not reported with one of the exposures
listed above after follow-up. See Technical Notes.
3Includes 1,474 men whose race/ethnicity is unknown.
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Table 15. Female adult/adolescent HIV infection cases (not AIDS) by exposure category and
race/ethnicity, reported July 1993 through June 1994, and cumulative totals
through June 1994, from states with confidential HIV infection reporting1













Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
Injecting drug use 284 (29) 1,063 (30) 643 (25) 2,125 (25) 73 (29) 207 (29)
Hemophilia/coagulation disorder – – 9 ( 0) 2 ( 0) 7 ( 0) – – – –
Heterosexual contact: 373 (39) 1,310 (37) 792 (30) 2,878 (34) 102 (40) 299 (42)
Sex with an injecting drug user 144 517 290  953 47 148
Sex with a bisexual male 48 179 64  216 4 11
Sex with person with hemophilia 10 45 5  21 – 5
Sex with transfusion recipient 
with HIV infection 9 20 5 24 1 4
Sex with HIV-infected person, 
risk not specified 162 549 428 1,664 50 131
Receipt of blood tranfusion, 
blood components, or tissue 23 ( 2) 105 ( 3) 44 ( 2) 144 ( 2) 5 ( 2) 16 ( 2)
Risk not reported or identified2 287 (30) 1,012 (29) 1,133 (43) 3,357 (39) 76 (30) 189 (27)
Total 967 (100) 3,499 (100) 2,614 (100) 8,511 (100) 256 (100) 711 (100)













Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Injecting drug use 1 ( 9) 4 (12) 9 (36) 35 (43) 1,019 (26) 3,464 (26)
Hemophilia/coagulation disorder – – – – – – – – 2 ( 0) 16 ( 0)
Heterosexual contact: 6 (55) 12 (36) 7 (28) 28 (34) 1,301 (33) 4,571 (35)
Sex with an injecting drug user 3 5 5 18 494 1,655
Se with a bisexual male – – 1 5 117 412
Sex with person with hemophilia – – – – 15 71
Sex with transfusion recipient 
with HIV infection – – – – 15 48
Sex with HIV-infected person, 
risk not specified 3 7 1 5 660 2,385
Receipt of blood tranfusion, 
blood components, or tissue – – 2 ( 6) – – 1 ( 1) 72 ( 2) 275 ( 2)
Risk not reported or identified 4 (36) 15 (45) 9 (36) 18 (22) 1,577 (40) 4,828 (37)
Total 11 (100) 33 (100) 25 (100) 82 (100) 3,971 (100) 13,154 (100)
1See Table 13 for states with confidential HIV infection reporting.
2For HIV infection cases (not AIDS), "Risk not reported or identified" refers primarily to persons whose mode of exposure was not reported and who
have not been followed up to determine their mode of exposure, and to a smaller number of persons who are not reported with one of the exposures
listed above after follow-up. See Technical Notes.
3Includes 318 women whose race/ethnicity is unknown.
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Table 16. HIV infection cases (not AIDS) by sex, age at diagnosis, and race/ethnicity, reported










Age at diagnosis (years) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Under 5 84 ( 0) 225 ( 1) 47 ( 2) 2 ( 2) 2 ( 1) 367 ( 1)
5–12 76 ( 0) 50 ( 0) 14 ( 1) – – 2 ( 1) 148 ( 0)
13–19 509 ( 2) 593 ( 3) 48 ( 2) 4 ( 3) 8 ( 3) 1,190 ( 2)
20–24 3,445 (15) 3,034 (14) 358 (14) 22 (18) 55 (19) 7,110 (15)
25–29 6,029 (26) 4,797 (22) 667 (25) 36 (30) 86 (30) 11,964 (24)
30–34 5,410 (24) 4,770 (22) 657 (25) 20 (17) 65 (23) 11,262 (23)
35–39 3,493 (15) 3,876 (18) 429 (16) 17 (14) 36 (13) 8,111 (17)
40–44 1,970 ( 9) 2,270 (11) 238 ( 9) 10 ( 8) 20 ( 7) 4,659 (10)
45–49 986 ( 4) 936 ( 4) 93 ( 4) 4 ( 3) 6 ( 2) 2,109 ( 4)
50–54 468 ( 2) 460 ( 2) 37 ( 1) 3 ( 3) 4 ( 1) 1,004 ( 2)
55–59 201 ( 1) 214 ( 1) 14 ( 1) – – 2 ( 1) 441 ( 1)
60–64 122 ( 1) 105 ( 0) 15 ( 1) – – 1 ( 0) 249 ( 1)
65 or older 106 ( 0) 91 ( 0) 9 ( 0) 1 ( 1) – – 225 ( 0)
Male subtotal 22,899 (100) 21,421 (100) 2,626 (100) 119 (100) 287 (100) 48,839 (100)
Female
Age at diagnosis (years)
Under 5 76 ( 2) 218 ( 2) 41 ( 5) 2 ( 6) 5 ( 6) 358 ( 3)
5–12 16 ( 0) 42 ( 0) 10 ( 1) 1 ( 3) 1 ( 1) 74 ( 1)
13–19 203 ( 6) 735 ( 8) 42 ( 6) – – 6 ( 7) 1,001 ( 7)
20–24 690 (19) 1,528 (17) 112 (15) 8 (22) 15 (17) 2,401 (18)
25–29 912 (25) 1,949 (22) 196 (26) 12 (33) 17 (19) 3,160 (23)
30–34 761 (21) 1,855 (21) 189 (25) 5 (14) 15 (17) 2,893 (21)
35–39 463 (13) 1,304 (15) 75 (10) 1 ( 3) 17 (19) 1,908 (14)
40–44 199 ( 6) 658 ( 8) 53 ( 7) 2 ( 6) 10 (11) 949 ( 7)
45–49 124 ( 3) 229 ( 3) 22 ( 3) 2 ( 6) 2 ( 2) 397 ( 3)
50–54 42 ( 1) 89 ( 1) 13 ( 2) 2 ( 6) – – 158 ( 1)
55–59 39 ( 1) 77 ( 1) 6 ( 1) – – – – 125 ( 1)
60–64 20 ( 1) 37 ( 0) 3 ( 0) – – – – 61 ( 0)
65 or older 46 ( 1) 50 ( 1) – – 1 ( 3) – – 101 ( 1)
Female subtotal 3,591 (100) 8,771 (100) 762 (100) 36 (100) 88 (100) 13,586 (100)
Total3 26,491 30,194 3,388 155 375 62,443 
1See Table 13 for states with confidential HIV infection reporting.
2Includes 1,487 males and 338 females whose race/ethnicity is unknown.
3Includes 18 persons whose sex is unknown.
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Surveillance of AIDS
All 50 states, the District of Columbia, U.S.
dependencies and possessions, and independent
nations in free association with the U.S.1 report
AIDS cases to CDC using a uniform surveillance
case definition and case report form. The original
definition was modified in 1985 (MMWR 1985;34:
373-5), in 1987 (MMWR 1987;36[suppl no.1S]:
1S-15S), and again in 1993 (MMWR 1992;41[no.
RR-17]:1-19; and MMWR 1994;43:160-1,167-70).
The revisions incorporated a broader range of
AlDS-indicator diseases and conditions and used
HIV diagnostic tests to improve the sensitivity and
specificity of the definition.
For persons with laboratory-confirmed HIV infec-
tion, the 1987 revision incorporated HIV encephal-
opathy, wasting syndrome, and other indicator
diseases that are diagnosed presumptively (i.e.,
without confirmatory laboratory evidence of the
opportunistic disease). In addition to the 23 clinical
conditions in the 1987 definition, the 1993 case def-
inition for adults and adolescents includes
HIV-infected persons with CD4+ T-lymphocyte
counts of less than 200 cells/µL or a CD4+ percent-
age of less than 14, and persons diagnosed with
pulmonary tuberculosis, recurrent pneumonia, and
invasive cervical cancer. All conditions added to the
1993 definition require laboratory confirmation of
HIV infection. Persons who meet the criteria for
more than one definition category are classified
hierarchically in the following order: pre-1987, 1987,
and 1993. Persons in the 1993 definition category
meet only the 1993 definition.
Although completeness of reporting of diagnosed
AIDS cases to state and local health departments
varies by geographic region and patient population,
studies conducted by state and local health depart-
ments indicate that reporting of AIDS cases in most
areas of the United States is more than 85 percent
complete (J Acquir Immune Def Syndr, 1992;5: 25-
764 and Am J Public Health 1992;82:1495-9). In
1Included among the dependencies, possessions, and independent
nations are Puerto Rico, the U.S. Virgin Islands, Guam, American
Samoa, the Republic of Palau, the Republic of the Marshall Islands,
the Commonwealth of the Northern Mariana Islands, and the Feder-
ated States of Micronesia. The latter 5 comprise the category “Pacific
Islands, U.S.” listed in Table 1.
addition, multiple routes of exposure, opportunistic
diseases diagnosed after the initial AIDS case
report was submitted to CDC, and vital status may
not be determined or reported for all cases.
Surveillance of HIV infection (not AIDS)
Through December 31, 1993, 25 states had laws
or regulations requiring confidential reporting by
name of all persons with confirmed HIV infection, in
addition to reporting of persons with AIDS. Another
state, Connecticut, required reporting by name of
HIV infection only for children less than 13 years of
age. These states initiated reporting at various
times after the development of serum HIV-antibody
tests in 1985. Before 1991, surveillance of HIV
infection was not standardized and reporting of HIV
infections was based primarily on passive surveil-
lance. Consequently, many cases reported before
1991 do not have complete information. Since then,
CDC has assisted states in conducting active sur-
veillance of HIV infection using standardized report
forms and software. However, collection of demo-
graphic and risk information still varies greatly
among states.
HIV infection data should be interpreted with cau-
tion. HIV surveillance reports are not representative
of all persons with HIV infection. Because many HIV
reporting states also offer anonymous HIV testing,
confidential HIV infection reports are not represen-
tative of all persons being tested in these areas.
Furthermore, many factors may influence testing
patterns, including the extent that testing is targeted
or routinely offered to specific groups and the avail-
ability and access to medical care and testing ser-
vices. These data provide a minimum estimate of
the number of persons known to be HIV infected in
states with confidential HIV infection reporting.
For this report, persons greater than 15 months
of age were considered HIV infected if they had at
least one positive Western blot or positive detection
test (culture, antigen, or other detection test) or had
a diagnosis of HIV infection documented by a physi-
cian. Children less than 15 months of age born to an
HIV-infected mother were considered HIV infected if
they met the definition stated in the pediatric classi-
fication system for HIV infection (see MMWR
Technical notes
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1987;36:225-30,235) or were diagnosed as HIV
infected by a physician. Although many states moni-
tor reports of children born to infected mothers,
among children less than 15 months, only those
with documented diagnosis of HIV infection are
included in this report.
Because states initiated reporting on different
dates, the length of time reporting has been in place
will influence the number of HIV infection cases
reported. For example, data presented for a given
annual period may include cases reported during
only a portion of the year. Prior to statewide HIV
reporting, some states collected reports of HIV
infection in selected populations. Therefore, these
states have reports prior to initiation of statewide
confidential reporting.
Over time, persons with HIV infection will be diag-
nosed and reported with AIDS. HIV infection cases
later reported with AIDS are deleted from the HIV
infection tables and added to the AIDS tables. Per-
sons with HIV infection may be tested at any point in
the clinical spectrum of disease, therefore the time
between diagnosis of HIV infection and AIDS will
vary. In addition, because surveillance practices dif-
fer, reporting and updating of clinical and vital status
of cases vary among states.
Tabulation and presentation of HIV infection 
and AIDS data
Data in this report are provisional. Each issue of
this report includes information received by CDC
through the last day of the previous quarter. AIDS
data are tabulated by date of report to CDC unless
otherwise noted. For HIV infection (not AIDS) cases
reported through December 31, 1993, the date HIV
cases were entered at the state or local health
department was used to determine the date
reported to CDC. Data for U.S dependencies and
possessions and for associated independent
nations are included in the totals.
Age group tabulations are based on the person's
age at first documented positive HIV-antibody test
result for HIV infection cases, and age at diagnosis
of AIDS for AIDS cases; adult/adolescent cases
include persons 13 years of age and older; pediatric
cases include children under 13 years of age. Age
group tabulations for AIDS cases in Table 14 (year-
end edition only) are based on age at death.
Tabulations of persons living with HIV and AIDS
(Table 23, year-end edition only), include persons
whose vital status was “alive” as of the last update. 
Table 2 lists AIDS cases counts for each metro-
politan area with 500,000 or more population. AIDS
cases counts for metropolitan areas with 50,000 to
500,000 population are reported as a combined
subtotal. On December 31, 1992, the Office of Man-
agement and Budget announced new Metropolitan
Statistical Area (MSA) definitions, which reflect
changes in the U.S. population as determined by
the 1990 census. These definitions were updated
most recently on July 1, 1994. The cities and coun-
ties which compose each metropolitan area listed in
Table 2 are provided in the publication “Revised
Statistical Definitions for Metropolitan Areas” (avail-
able from the National Technical Information Ser-
vice, 1-703-487-4650, and ordering accession no.
PB94-165-628). Standards for defining central and
outlying counties of metropolitan areas were pub-
lished in the Federal Register (see FF 1990;55;
12154-60).
The metropolitan area definitions are the MSAs
for all areas except the 6 New England states. For
these states, the New England County Metropolitan
Areas (NECMA) are used. Metropolitan areas are
named for a central city in the MSA or NECMA, may
include several cities and counties, and may cross
state boundaries. For example, AIDS cases and
annual rates presented for the District of Columbia
in Table 1 include only persons residing within the
geographic boundaries of the District. AIDS cases
and annual rates for Washington, D.C., in Table 2
include persons residing within the several counties
in the metropolitan area, including counties in Mary-
land, Virginia, and West Virginia. State or metropoli-
tan area data tabulations are based on the person's
residence at first positive HIV-antibody test result
for HIV infection cases and residence at diagnosis
of the first AIDS-indicator condition(s) for AIDS
cases.
Exposure categories
For surveillance purposes, HIV infection cases
and AIDS cases are counted only once in a hierar-
chy of exposure categories. Persons with more than
one reported mode of exposure to HIV are classified
in the exposure category listed first in the hierarchy,
except for men with both a history of sexual contact
with other men and injecting drug use. They make
up a separate exposure category.
“Men who have sex with men” cases include men
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who report sexual contact with other men (i.e.,
homosexual contact) and men who report sexual
contact with both men and women (i.e., bisexual
contact). “Heterosexual contact” cases are in per-
sons who report specific heterosexual contact with
a person with, or at increased risk for, HIV infection
(e.g., an injecting drug user).
Adults/adolescents born, or who had sex with
someone born, in a country where heterosexual
transmission was believed to be the predominant
mode of HIV transmission (formerly classified as
Pattern-II countries by the World Health Organiza-
tion) are no longer classified as having heterosexu-
ally acquired AIDS. Similar to case reports for other
persons who are reported without behavioral or
transfusion risks for HIV, these reports are now
classified (in the absence of other risk information
which would classify them into another exposure
category) as “no risk reported or identified” (see
MMWR 1994;43:155-60). Children whose mother
was born, or whose mother had sex with someone
born, in a Pattern-II country are now classified (in
the absence of other risk information which would
classify them into another exposure category) as
“Mother with/at risk for HIV infection: has HIV infec-
tion, risk not specified.”
“Risk not reported or identified” cases are in per-
sons with no reported history of exposure to HIV
through any of the routes listed in the hierarchy of
exposure categories. “Risk not reported or identi-
fied” cases include persons who are currently under
investigation by local health department officials;
persons whose exposure history is incomplete
because they died, declined to be interviewed, or
were lost to follow-up; and persons who were inter-
viewed or for whom other follow-up information was
available and no exposure mode was identified.
Persons who have an exposure mode identified at
the time of follow-up are reclassified into the appro-
priate exposure category. In general, investigations
and follow-up for modes of exposure by state health
departments are conducted routinely for persons
reported with AIDS and, as resources allow, for
those reported with HIV infection. Therefore, the
percentage of HIV-infected persons with risk not
reported or identified is substantially higher than for
those reported with AIDS.
Rates
Rates are calculated on an annual basis per
100,000 population for AIDS cases only. Rates are
not calculated for HIV infection reports because
case counts for HIV infection are believed to be less
complete than AIDS case counts. Population
denominators for computing AIDS rates for the 50
states and the District of Columbia are based on
official post-census estimates from the U.S. Bureau
of Census. Denominators for U.S. dependencies
and possessions are linear extrapolations of official
1980 and 1990 census counts. Each 12-month rate
is the number of cases reported during the
12-month period, divided by the 1992 or 1993 popu-
lation, multiplied by 100,000. The denominators for
computing race-specific rates (Table 10, year-end
edition only) are based on 1990 census projections
published in U.S. Bureau of Census publication
P25-1092, “Population Projections of the United
States, by Age, Sex, Race, and Hispanic Origin:
1992 to 2050.” Race-specific rates are the number
of cases reported for a particular racial/ethnic group
during the preceding 12-month period divided by
the projected population for that race/ethnicity, mul-
tiplied by 100,000.
Case-fatality rates are calculated for each half-
year by date of diagnosis of AIDS. Each 6-month
case-fatality rate is the number of deaths ever
reported among cases diagnosed in that period
(regardless of the year of death), divided by the
number of total cases diagnosed in that period, mul-
tiplied by 100. Reported deaths are not necessarily
caused by HIV-related disease. Caution should be
used in interpreting case-fatality rates because
reporting of deaths is incomplete (see Am J Public
Health 1992;82:1500-5 and Am J Public Health
1990;80: 1080-6).
Reporting delays
Reporting delays (time between diagnosis of HIV
infection or AIDS and report to CDC) vary widely
among exposure, geographic, racial/ethnic, age and
sex categories, and have been as long as several
years for some AIDS cases. About 50 percent of all
AIDS cases were reported to CDC within 3 months
of diagnosis, with about 20 percent being reported
more than one year after diagnosis. Reporting delay
for HIV infection cases is being evaluated.
